Breaking News Instant updates and real-time market news.

2018-09-24 17:18:35 CPT Camden Property $93.35 -1.6 (-1.69%) 17:18 09/24/18 09/24 17:18 09/24/18 17:18	Camden Property completes acquisition of Florida apartment community Camden Property Trust announced that it has completed the acquisition of a recently constructed 299-home apartment community in Orlando for a total purchase price of approximately $90M. The community is a 9-story high-rise in downtown Orlando built in 2016 featuring a 4th floor pool and amenity deck, 24-hour concierge, retail space and a 3-story parking garage. The community will be renamed Camden Thornton Park and is adjacent to Camden Lake Eola, a new development community which recently started construction.	25 Sep
CPT Camden Property $93.35 -1.6 (-1.69%) 03/19/18 UBSW 03/19/18 UPGRADE Target $84 UBSW Neutral Camden Property upgraded to Neutral from Sell at UBS UBS analyst Nicholas Yulico upgraded Camden Property Trust to Neutral while lowering his price target for the shares to $84 from $89. The analyst views the valuation as "more reasonable" at current share levels. 05/31/18 GSCO 05/31/18 UPGRADE Target $102 GSCO Conviction Buy Camden Property upgraded to Conviction Buy from Buy at Goldman Sachs Goldman Sachs analyst Andrew Rosivach added Camden Property Trust to his firm's Americas Conviction List while keeping a Buy rating on the shares with a 12-month price target of $102. Recent reports imply U.S. employment growth has stabilized after decelerating from Q1 of 2015 levels, which creates a favorable macro environment for Camden, Rosivach tells investors in a research note. He calls the company a "standout" in multifamily REITs. 08/14/18 RBCM 08/14/18 NO CHANGE Target $97 RBCM Outperform Camden Property price target raised to $97 from $92 at RBC Capital RBC Capital analyst Wes Golladay raised his price target on Camden Property to $97 and kept his Outperform rating, citing the company's "healthy organic and external growth along with a well capitalized balance sheet". The analyst states that the accelerated activity in the REIT's top markets of DC and Houston is driving same-store revenue growth of 2.5% and 3.7% respectively, and anticipates the impact from the recent acquisitions to add an "extra layer of growth" for Camden through 2020 08/14/18 RHCO 08/14/18 NO CHANGE Target $95 RHCO Hold Camden Property price target raised to $95 from $86 at SunTrust SunTrust analyst Michael Lewis raised his price target on Camden Property to $95, saying the company's Q2 saw improved operations in its two biggest markets - Houston and Washington DC. Lewis notes that the strong job growth should allow the Sun Belt REIT market to outperform in the near term, but keeps his Hold rating on Camden Property, adding that its implied valuation of an 8% discount to NAV is already less than the 9% 5-year average.

2018-09-24 17:18:35

CPT

Camden Property

$93.35: -1.6 (-1.69%)

17:18

09/24/18

09/24

17:18

09/24/18

17:18

Camden Property completes acquisition of Florida apartment community

Camden Property Trust announced that it has completed the acquisition of a recently constructed 299-home apartment community in Orlando for a total purchase price of approximately $90M. The community is a 9-story high-rise in downtown Orlando built in 2016 featuring a 4th floor pool and amenity deck, 24-hour concierge, retail space and a 3-story parking garage. The community will be renamed Camden Thornton Park and is adjacent to Camden Lake Eola, a new development community which recently started construction.

25
Sep

CPT Camden Property

$93.35: -1.6 (-1.69%)

03/19/18: UBSW

05/31/18: GSCO

08/14/18: RBCM

08/14/18: RHCO

TODAY'S FREE FLY STORIES

AMZN Amazon.com $1,608.88 -13.47 (-0.83%) 12:45 02/16/19 02/16 12:45 02/16/19 12:45 Periodicals	Protestors against NY's Amazon HQ2 got math wrong, Barron's says » On Thursday, Amazon… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	16 Feb 20 Feb 20 Feb 03 Mar 18 Mar
ICE IntercontinentalExchange $75.49 -0.46 (-0.61%) , NDAQ Nasdaq $87.74 0.56 (0.64%) … 12:28 02/16/19 02/16 12:28 02/16/19 12:28 Periodicals	Investors interested in U.S. cannabis companies face challenges, Barron's says » Investors interested in… ICE IntercontinentalExchange $75.49 -0.46 (-0.61%) NDAQ Nasdaq $87.74 0.56 (0.64%) CGC Canopy Growth $47.54 1.49 (3.24%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	18 Feb 28 May 15 Feb
AMD AMD $23.68 0.55 (2.38%) , INTC Intel $51.64 0.85 (1.67%) … 08:43 02/16/19 02/16 08:43 02/16/19 08:43 On The Fly	Week in review: How Trump's policies moved stocks » Catch up on the top… Open Full Text AMD AMD $23.68 0.55 (2.38%) INTC Intel $51.64 0.85 (1.67%) MRVL Marvell $18.82 -0.37 (-1.93%) MCHP Microchip $91.10 0.49 (0.54%) MU Micron $41.99 -0.23 (-0.54%) NVDA Nvidia $157.22 2.69 (1.74%) QCOM Qualcomm $51.97 0.42 (0.81%) TXN Texas Instruments $107.55 0.57 (0.53%) TWTR Twitter $31.23 0.28 (0.90%) 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	20 Feb 21 Feb 25 Feb 07 Mar 07 Mar 25 Mar 26 Mar 28 May 04 Jun 05 Jun
AMGN Amgen $188.31 1.6 (0.86%) , ALPMY Astellas Pharma $0.00 (0.00%) … 04:55 02/16/19 02/16 04:55 02/16/19 04:55 Conference/Events	American Society of Clinical Oncology to hold a symposium » 2019 ASCO Genitourinary… AMGN Amgen $188.31 1.6 (0.86%) ALPMY Astellas Pharma $0.00 (0.00%) AZN AstraZeneca $40.92 0.93 (2.33%) BAYRY Bayer $0.00 (0.00%) BMY Bristol-Myers $51.64 0.81 (1.59%) CALA Calithera Biosciences $5.35 0.14 (2.69%) CLVS Clovis $25.44 (0.00%) DNA Bought by RHHBY $0.00 (0.00%) ESALY Eisai $0.00 (0.00%) EXEL Exelixis $22.26 -0.05 (-0.22%) IMMU Immunomedics $14.23 0.225 (1.61%) INO Inovio $3.70 0.01 (0.27%) MRK Merck $79.84 0.9 (1.14%) MYOV Myovant Sciences $21.48 0.1 (0.47%) MYGN Myriad Genetics $31.41 0.53 (1.72%) NH NantHealth $0.60 (0.00%) NVS Novartis $89.89 0.865 (0.97%) PFE Pfizer $42.41 0.45 (1.07%) PGNX Progenics $4.87 0.13 (2.74%) SGEN Seattle Genetics $71.48 2.92 (4.26%) SNY Sanofi $42.51 0.94 (2.26%) TYME Tyme Technologies $3.19 0.055 (1.76%) AVEO Aveo Pharmaceuticals $0.62 0.0092 (1.51%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	16 Feb 16 Feb 19 Feb 20 Feb 25 Feb 26 Feb 26 Feb 28 Feb 07 Mar 11 Mar 22 Mar 11 Apr 28 Apr 18 May 20 May
WES Western Gas Partners $49.52 0.38 (0.77%) , WGP Western Gas Equity $32.38 0.2 (0.62%) 19:30 02/15/19 02/15 19:30 02/15/19 19:30 Recommendations	Western Gas Partners, Western Gas Equity analyst commentary at MUFG » MUFG raises price targets… MUFG raises price targets on Western Gas Partners to $55 from $50. MUFG analyst Barrett Blaschke raised his price target on Western Gas Partners (WES) to $55 with a Neutral rating and also lowered his price target on Western Gas Equity (WGP) to $42 from $45 with an Overweight rating ahead of the simplification combination of the two entities. The analyst notes that Western Gas experienced weather-related issues and operational challenges in Q4, and that without the accounting change adjustment, its EBITDA would have missed consensus. Blaschke maintains however that the simplification process under which Western Midstream Partners will be an IDR-free MLP and thus able to take advantage of the federal tax break of MLP status is the core focus for investors. WES Western Gas Partners $49.52 0.38 (0.77%) WGP Western Gas Equity $32.38 0.2 (0.62%) 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	15 Feb 15 Feb 04 Mar

PXD Pioneer Natural $145.33 2.27 (1.59%) 19:19 02/15/19 02/15 19:19 02/15/19 19:19 Recommendations	Pioneer Natural analyst commentary at MUFG » Pioneer Natural price… Pioneer Natural price target lowed to $192 from $223 at MUFG. MUFG analyst Michael McAllister lowered his price target on Pioneer Natural to $192 after its Q4 EPS and EBITDA miss, with costs coming in 2% and exploration expense reported $10M higher than he expected. The analyst also lowers his FY20 production forecast to 13% vs. 18% prior forecast. McAllister keeps his Overweight rating on the stock, saying its implied enterprise value to EBITDA multiple of 8-times that is a premium to 6-times universe average is warranted "due to its top-tier acreage position, strength of its balance sheet, oil production growth and free cashflow potential". 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	22 May
ZTS Zoetis $95.38 2.16 (2.32%) 18:42 02/15/19 02/15 18:42 02/15/19 18:42 Hot Stocks	Zoetis CEO says: 'Diagnostics are more important in animals than humans' » In an interview on… In an interview on CNBC's Mad Money, Zoetis CEO Juan Ramon Alaix said: "Diagnostics are more important in animals than humans... We are doing very well in China... China is the third largest country for us... Apoquel is treating allergic reactions in dogs and it's doing very well." 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
JNJ Johnson & Johnson $136.40 2.13 (1.59%) 18:22 02/15/19 02/15 18:22 02/15/19 18:22 Hot Stocks	Johnson & Johnson CEO: 'We ended 2018 with great results' » In an interview on… In an interview on CNBC's Mad Money, Johnson & Johnson CEO Alex Gorsky said: "We ended 2018 with great results... We could not be more proud of Esketamine... One of the most exciting parts of my job is seeing technology being integrated with healthcare... Less than 5% of surgeries are performed by a robot, we think that can be greater." 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	18 Feb 25 Feb 25 Feb 06 Mar
WIN Windstream $3.37 0.2 (6.31%) , UNIT Uniti Group $20.00 0.53 (2.72%) 18:18 02/15/19 02/15 18:18 02/15/19 18:18 Periodicals	Court says Windstream defaulted on bonds in 2015, Bloomberg says » A court has ruled that… A court has ruled that Windstream Holdings (WIN) defaulted on its bonds in 2015 by spinning off Uniti Group (UNIT), Bloomberg's Allison McNeely and Tiffany Kary report. The ruling in Manhattan federal court is a victory for Aurelius Capital, which argues taht the deal unfairly took assets away from bondholers that back up their investment, the reporters say. Windstream has warned that a loss could force it into bankruptcy, McNeely and Kary note. Reference Link WIN Windstream $3.37 0.2 (6.31%) UNIT Uniti Group $20.00 0.53 (2.72%) 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	25 Feb 28 Feb
BHVN Biohaven Pharmaceutical $45.32 1.36 (3.09%) 18:14 02/15/19 02/15 18:14 02/15/19 18:14 Hot Stocks	Biohaven treatment of multiple system atrophy granted FDA orphan designation » According to a post on… According to a post on the FDA's website, Biohaven Pharmaceutical's treatment of multiple system atrophy was granted orphan designation. Reference Link 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial

AMGN Amgen $188.31 1.6 (0.86%) 18:11 02/15/19 02/15 18:11 02/15/19 18:11 Hot Stocks	Amgen treatment of Acute Myeloid Leukemia granted FDA orphan designation » According to a post on… According to a post on the FDA's website, Amgen's treatment of Acute Myeloid Leukemia was granted orphan designation. Reference Link 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
CE Celanese $100.19 1.19 (1.20%) 18:02 02/15/19 02/15 18:02 02/15/19 18:02 Hot Stocks	Celanese announces Acetyl Intermediates price increases in China » Celanese will increase… Celanese will increase list and off-list selling prices for the following acetyl intermediates products. The price increases are CNY550/MT for Acetic Acid, CNY300/MT for Vinyl Acetate Monomer, CNY575/MT for Acetic Anhydride, and CNY100/MT for Vinyl Acetate-based Emulsions. 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
WIN Windstream $3.37 0.2 (6.31%) , UNIT Uniti Group $20.00 0.53 (2.72%) 17:58 02/15/19 02/15 17:58 02/15/19 17:58 Periodicals	Court says Windstream defaulted on bonds in 2015, Bloomberg says » A court has ruled that… A court has ruled that Windstream Holdings (WIN) defaulted on its bonds in 2015 by spinning off Uniti Group (UNIT), Bloomberg reports. The ruling in Manhattan federal court is a victory for Aurelius Capital, which argues taht the deal unfairly took assets away from bondholers that back up their investment, the report says. WIN Windstream $3.37 0.2 (6.31%) UNIT Uniti Group $20.00 0.53 (2.72%) 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	25 Feb 28 Feb
GLD SPDR Gold Shares $124.81 0.77 (0.62%) 17:41 02/15/19 02/15 17:41 02/15/19 17:41 Hot Stocks	SPDR Gold Shares holdings fall to 793.03MT from 796.85MT » This is the lowest level… This is the lowest level of holdings since December 31, 2018. 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
MDLZ Mondelez $48.17 0.84 (1.77%) 17:26 02/15/19 02/15 17:26 02/15/19 17:26 Hot Stocks	Mondelez to transfer listing of debt securities to Nasdaq » Mondelez International,… Mondelez International, Inc. announced its intention to transfer the securities exchange listing for its notes listed below from the New York Stock Exchange to the Nasdaq Bond Exchange effective February 25, 2019 after market close. The debt securities are expected to begin trading on the Nasdaq Bond Exchange on February 26, 2019. 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	18 Feb 06 Mar 28 May

FN Fabrinet $55.23 0.67 (1.23%) 17:25 02/15/19 02/15 17:25 02/15/19 17:25 Hot Stocks	Fabrinet CFO sells 20K shares of common stock » In a regulatory filing,… In a regulatory filing, Fabrinet CFO Toh-Seng Ng disclosed a February 14th-15th sale of 20K shares of common stock at an average price of $54.73 per share. The total transaction size was $1.09M. 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	26 Feb 27 Feb 28 Feb 04 Mar
UBER Uber $0.00 (0.00%) 17:24 02/15/19 02/15 17:24 02/15/19 17:24 Periodicals	Uber sues NYC over move to cap number of ride-hailing drivers, Bloomberg says » Uber is suing New York… Uber is suing New York City over a government decision to limit the number of ride-hailing drivers allowed on the streets, Bloomberg's Eric Newcomer reports. Officials partly justified such caps on for-hire drivers as a way to cut down on congestion, Newcomer notes. In the lawsuit, Uber contends that the city doesn't have the evidence to prove that claim and alleges that Mayor Bill de Blasio is treating the business unfairly, the author says. Reference Link 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
SPX S&P 500 $0.00 (0.00%) , SPY SPDR S&P 500 ETF Trust $277.40 2.93 (1.07%) 17:19 02/15/19 02/15 17:19 02/15/19 17:19 Periodicals	House Democrats to probe POTUS emergency declaration, Bloomberg says » The House Judiciary… The House Judiciary Committee intends to investigate the "serious constitutional and statutory issues" raised by U.S. President Donald Trump's declaration of emergency on the southern border, Bloomberg's Billy House reports. The committee, led by Democrat Jerrold Nadler, asked the White Hose to make available for a hearing administration employees involved in the declaration that redirects roughly $7B in the federal budget to build a wall on the U.S.-Mexico border, House says. Reference Link SPX S&P 500 $0.00 (0.00%) SPY SPDR S&P 500 ETF Trust $277.40 2.93 (1.07%) 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
ORCL Oracle $51.71 0.25 (0.49%) 17:11 02/15/19 02/15 17:11 02/15/19 17:11 Hot Stocks	Oracle authorizes additional $12B stock buyback under existing program » In a regulatory 8K… In a regulatory 8K filing, Oracle states that on February 12th, its board authorized the repurchase of up to an additional $12.0 billion of common stock under an existing share repurchase program. The stock repurchase authorization does not have an expiration date and the pace of repurchase activity will depend on factors such as Oracle's working capital needs, cash requirements for acquisitions and dividend payments, debt repayment obligations or repurchases of Oracle's debt, Oracle's stock price, and economic and market conditions. 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	03 Mar 06 Mar
SBLK Star Bulk Carriers $8.21 0.13 (1.61%) 17:03 02/15/19 02/15 17:03 02/15/19 17:03 Hot Stocks	Star Bulk Carriers acquires 95,605 of its common shares » Star Bulk Carriers… Star Bulk Carriers announced that, pursuant to the company's previously announced share repurchase program, the company purchased today 95,605 of its common shares in open market transactions at an average price of $8.1937 for aggregate consideration of $783,359. The company shall cancel all the common shares it has repurchased. 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial

HOLI Hollysys $20.56 0.26 (1.28%) 17:02 02/15/19 02/15 17:02 02/15/19 17:02 Earnings	Hollysys reports Q2 adjusted EPS 73c, consensus 59c » Reports Q2 revenue… Reports Q2 revenue $149.5M, consensus $177.08M. Non-GAAP gross margin was at 38.2%, compared to 39.4% for the comparable prior year period. 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	17 Feb
AKS AK Steel $2.98 -0.015 (-0.50%) 16:58 02/15/19 02/15 16:58 02/15/19 16:58 Syndicate	Breaking Syndicate news story on AK Steel » AK Steel files automatic… AK Steel files automatic mixed securities shelf 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
16:55 02/15/19 02/15 16:55 02/15/19 16:55 General news	Treasury Market Summary: i » Treasury Market Summary:… Treasury Market Summary: it was all about equities as the markets headed into the long Presidents' Day weekend. Treasuries went along for the ride and were little changed by the close despite the jump in risk appetite, with the long end outperforming. Wall Street put the shockingly weak retail sales report behind it and was buoyed by hopes of a U.S.-China trade deal, improved data, and as another government shutdown was averted. The Dow rallied 1.74% to 25,883, while the S&P 500 was up over 1.0% to 2,775. Despite the strength in risk appetite, bonds were little changed, supported by tame inflation data. The long end outperformed. The 30-year Treasury yield closed 0.5 bps lower at 2.993%, after hitting a high of 3.02%. The 2-year rose 2 bps to 2.51%. Fedspeakers Bostic and Daly continued to support the patient policy approach.View the summary.
LPTX Leap Therapeutics $1.65 (0.00%) 16:53 02/15/19 02/15 16:53 02/15/19 16:53 Hot Stocks	Valence Helix Investments discloses 10.99% stake in Leap Therapeutics » Valence Helix disclosed a… Valence Helix disclosed a 10.99% passive stake in Leap Therapeutics. The stake represents just under 2.6M shares. The Reporting Persons do not have any plans or proposals that relate or would result in extraordinary corporate transactions, material change in the present capitalization or dividend policy, or any other material change in the issuer's business or corporate structure. 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
MPB Mid Penn Bancorp $23.25 -0.24 (-1.02%) 16:52 02/15/19 02/15 16:52 02/15/19 16:52 Hot Stocks	Mid Penn Bancorp seeks approval to relocate Allentown Boulevard branch » Mid Penn Bank, subsidiary… Mid Penn Bank, subsidiary of Mid Penn Bancorp, Inc. is seeking regulatory approval to relocate its branch in Lower Paxton Township, Dauphin County, from 5500 Allentown Boulevard to 5049 Jonestown Road. The bank recently submitted an application to the Pennsylvania Department of Banking and Securities and to the Federal Deposit Insurance Corporation. Customers will be provided the amenities of a full-service branch in a more accessible location. 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial

Events

Earnings calls, analyst events, roadshows and more

Tomorrow at 00:00

Toy Fair 2019 Conferences

Jacob K. Javits Center, New York, NY
HOLI
Tomorrow at 20:00

Hollysys - HOLI Conference Calls
ALXN
2019-02-18 at 00:00

PDUFA Date for AALXN1210 Government Event
2019-02-18 at 00:00

Toy Fair 2019 Conferences

Jacob K. Javits Center, New York, NY
2019-02-18 at 00:00

Taiwan CEO-CFO Conference Conferences

Taipei
GIS ...
2019-02-18 at 00:00

CAGNY Conference 2019 Conferences

New York, NY
DDAIF
2019-02-18 at 00:00

Daimler AG Firm Sponsored Meetings

New York, NY
2019-02-18 at 03:00

Economics & Strategy--Asia Industry Meetings
CUB
2019-02-18 at 14:30

Cubic Firm Sponsored Meetings

Co Offices--9333 Balboa Avenue, San Diego, CA
2019-02-19 at 00:00

Taiwan CEO-CFO Conference Conferences

Taipei

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	ANCN X ANCN Anchiano Therapeutics IPO Managers: Oppenheimer, Ladenburg Priced at: $11.50 2.6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MITT X MITT AG Mortgage Spot Secondary Managers: Morgan Stanley, JMP Securities Priced at: $17.05 3M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial NMFC X NMFC New Mountain Finance Spot Secondary Managers: Wells Fargo, Morgan Stanley, Goldman Sachs & Keefe Bruyette, Janney Montgomery Scott, Oppenheimer Priced at: $13.57 3.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PMT X PMT PennyMac Mortgage Spot Secondary Managers: Credit Suisse, BofA/Merrill, Deutsche Bank, Morgan Stanley & Goldman Sachs Priced at: $20.64 7M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	G X G Genpact Block Trade Managers: Goldman Sachs Priced at: $32.40 10M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial GLIBA X GLIBA GCI Liberty Block Trade Managers: UBS Priced at: $51.60 1.47M Shares MGNX X MGNX MacroGenics Spot Secondary Managers: SVB Leerink & Evercore ISI Priced at: $20.00 5.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	HUBS X HUBS HubSpot Block Trade Managers: Morgan Stanley Priced at: $165.00 1.9M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MYOK X MYOK MyoKardia Block Trade Managers: Morgan Stanley Priced at: $39.00 2M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AVDR X AVDR Avedro IPO Managers: BofA/Merrill & JPMorgan, Cowen, Guggenheim, SVB Leerink Priced at: $14.00 5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial TCRR X TCRR TCR2 Therapeutics IPO Managers: Jefferies, SVB Leerink & BMO Capital, Wedbush, China Renaissance Priced at: $15.00 5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial XERS X XERS Xeris Pharmaceuticals Secondary Managers: Jefferies, SVB Leerink, RBC Capital & MIZU Priced at: $10.00 5.88M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	ICE X ICE IntercontinentalExchange Block Trade Managers: Morgan Stanley Priced at: $75.00 6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MITO X MITO Stealth Biotherapeutics IPO Managers: Jefferies, Evercore ISI & BMO Capital, Nomura Instinet Priced at: $12.00 6.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AKAO X AKAO Achaogen Spot Secondary Managers: H.C. Wainwright Priced at: $1.00 15M Shares REED X REED Reed's Spot Secondary Managers: Roth Capital Priced at: $2.10 6.725M Shares
Fri	No deals

Mon	No deals
Tues	VTUS X VTUS Virgin Trains IPO Managers: Barclays, JPMorgan & Morgan Stanley, BofA/Merrill, Allen & Co., JMP Securities, Raymond James $17.00-19.00 28.33M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	CBUS X CBUS Cibus IPO Managers: Morgan Stanley & BofA/Merrill, Piper Jaffray, BMO Capital $14.00-16.00 6.667M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	No deals
Fri	No deals

View All Syndicate Announcements »

Camden Property completes acquisition of Florida apartment community

TODAY'S FREE FLY STORIES

Get Full Fly Access